StageZero Life Sciences Announces First Closing of CDN $3.7 Million Private Placement
TORONTO, ON / ACCESSWIRE / July 11, 2019 / StageZero Life Sciences Ltd (TSX: SZLS)…
user
YIELD GROWTH Announces Definitive Agreement for Exclusive Distribution of Urban Juve Products in Greece and Cyprus
VANCOUVER, BC / ACCESSWIRE / July 11, 2019 / The Yield Growth Corp. (OTCQB:BOSQF) (CSE:BOSS)…
Intellipharmaceutics Announces Second Quarter 2019 Results
TORONTO, ON / ACCESSWIRE / July 10, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and…
Co2 GRO Inc. Announces the Appointment of Dr. Matthew Julius as Chief Science Officer
TORONTO, ON / ACCESSWIRE / July 10, 2019 Toronto based CO2GRO Inc. (“GROW”) (TSX-V: GROW,…
Avinger Enrolls First 50 Patients in INSIGHT Clinical Trial
Positive early outcomes in complex in-stent restenosis cases with few therapeutic options REDWOOD CITY, CA…
Nuzuna Zone Fitness Welcomes Thomas O’Neill to its Board
COSTA MESA, CA / ACCESSWIRE / July 10, 2019 / Nuzuna Zone Fitness is pleased…
International Cannabrands Announces Financing Engagement Co-Led by Gravitas Securities and Canaccord Genuity
Not for Dissemination to United States Newswire Services or for Dissemination in the United States…
Biom’up Provides Business Update for the First Half of 2019 and confirms its Revenue Guidance for the year
Global, unaudited sales of HEMOBLAST(TM) Bellows for the first half of 2019 were EUR1.4 million…
Calidi Biotherapeutics Announces Global Oncolytic Virus-based Immunotherapy License to VetStem Biopharma for its Pioneering Treatment of Cancer in the Veterinary Field
SAN DIEGO, CA / ACCESSWIRE / July 10, 2019 / Calidi Biotherapeutics, Inc., a clinical‐stage…
Kadmon Doses First Patient in Phase 2 Clinical Trial of KD025 in Systemic Sclerosis
NEW YORK, NY / ACCESSWIRE / July 9, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN)…